APO Research

APO RESEARCH · REPORT

General Anesthetics

Selected research

Industry Growth & Trends

Global General Anesthetics Industry Growth and Trends Forecast to 2032

Market perspective

The global General Anesthetics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for General Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for General Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for General Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of General Anesthetics include Eisai, Johnson & Johnson, Merck, Jiangsu Hengrui Pharmaceutical Co., Ltd., GlaxoSmithKline, Fresenius Kabi AG, Baxter International, AbbVie and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global General Anesthetics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The General Anesthetics market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global General Anesthetics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to General Anesthetics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global General Anesthetics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

General Anesthetics Market by Company

Eisai

Johnson & Johnson

Merck

Jiangsu Hengrui Pharmaceutical Co., Ltd.

GlaxoSmithKline

Fresenius Kabi AG

Baxter International

AbbVie

AstraZeneca

Lannett

Hikma Pharmaceuticals

Endo International

Boehringer Ingelheim

B. Braun Melsungen AG

Aspen Pharmacare

Abbott Laboratories

General Anesthetics Segment by Type

Inhalation Anesthestic

Intravenous Anesthestic

General Anesthetics Segment by Application

Hospital

Ambulatory Surgery Center

Others

General Anesthetics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Anesthetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of General Anesthetics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Anesthetics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of General Anesthetics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of General Anesthetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Inhalation Anesthestic Table 2. Major Company of Intravenous Anesthestic Table 3. Global General Anesthetics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global General Anesthetics Sales by Type (2021-2026) & (k units) Table 5. Global General Anesthetics Sales Market Share in Volume by Type (2021-2026) Table 6. Global General Anesthetics Sales by Type (2021-2026) & (US$ Million) Table 7. Global General Anesthetics Sales Market Share in Value by Type (2021-2026) Table 8. Global General Anesthetics Price by Type (2021-2026) & (US$/unit) Table 9. Global General Anesthetics Sales by Type (2027-2032) & (k units) Table 10. Global General Anesthetics Sales Market Share in Volume by Type (2027-2032) Table 11. Global General Anesthetics Sales by Type (2027-2032) & (US$ Million) Table 12. Global General Anesthetics Sales Market Share in Value by Type (2027-2032) Table 13. Global General Anesthetics Price by Type (2027-2032) & (US$/unit) Table 14. North America General Anesthetics Sales by Type (2021-2026) & (k units) Table 15. North America General Anesthetics Sales by Type (2021-2026) & (US$ Million) Table 16. Europe General Anesthetics Sales by Type (2021-2026) & (k units) Table 17. Europe General Anesthetics Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific General Anesthetics Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific General Anesthetics Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America General Anesthetics Sales by Type (2021-2026) & (k units) Table 21. Latin America General Anesthetics Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa General Anesthetics Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa General Anesthetics Sales by Type (2021-2026) & (US$ Million) Table 24. General Anesthetics Industry Trends Table 25. General Anesthetics Industry Drivers Table 26. General Anesthetics Industry Opportunities and Challenges Table 27. General Anesthetics Industry Restraints Table 28. Global General Anesthetics Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global General Anesthetics Revenue Market Share by Company (2021-2026) Table 30. Global General Anesthetics Sales by Company (2021-2026) & (k units) Table 31. Global General Anesthetics Sales Share by Company (2021-2026) Table 32. Global General Anesthetics Market Price by Company (2021-2026) & (US$/unit) Table 33. Global General Anesthetics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global General Anesthetics Major Company Production Sites and Headquarters Table 35. Global General Anesthetics Company, Product Type & Application Table 36. Global General Anesthetics Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global General Anesthetics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global General Anesthetics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global General Anesthetics Sales by Region (2021-2026) & (k units) Table 41. Global General Anesthetics Sales Market Share in Volume by Region (2021-2026) Table 42. Global General Anesthetics Sales by Region (2021-2026) & (US$ Million) Table 43. Global General Anesthetics Sales Market Share in Value by Region (2021-2026) Table 44. Global General Anesthetics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global General Anesthetics Sales by Region (2027-2032) & (k units) Table 46. Global General Anesthetics Sales Market Share in Volume by Region (2027-2032) Table 47. Global General Anesthetics Sales by Region (2027-2032) & (US$ Million) Table 48. Global General Anesthetics Sales Market Share in Value by Region (2027-2032) Table 49. Global General Anesthetics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global General Anesthetics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global General Anesthetics Sales by Application (2021-2026) & (k units) Table 52. Global General Anesthetics Sales Market Share in Volume by Application (2021-2026) Table 53. Global General Anesthetics Sales by Application (2021-2026) & (US$ Million) Table 54. Global General Anesthetics Sales Market Share in Value by Application (2021-2026) Table 55. Global General Anesthetics Price by Application (2021-2026) & (US$/unit) Table 56. Global General Anesthetics Sales by Application (2027-2032) & (k units) Table 57. Global General Anesthetics Sales Market Share in Volume by Application (2027-2032) Table 58. Global General Anesthetics Sales by Application (2027-2032) & (US$ Million) Table 59. Global General Anesthetics Sales Market Share in Value by Application (2027-2032) Table 60. Global General Anesthetics Price by Application (2027-2032) & (US$/unit) Table 61. North America General Anesthetics Sales by Application (2021-2026) & (k units) Table 62. North America General Anesthetics Sales by Application (2021-2026) & (US$ Million) Table 63. Europe General Anesthetics Sales by Application (2021-2026) & (k units) Table 64. Europe General Anesthetics Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific General Anesthetics Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific General Anesthetics Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America General Anesthetics Sales by Application (2021-2026) & (k units) Table 68. Latin America General Anesthetics Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa General Anesthetics Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa General Anesthetics Sales by Application (2021-2026) & (US$ Million) Table 71. Eisai Company Information Table 72. Eisai Business Overview Table 73. Eisai General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Eisai General Anesthetics Product Portfolio Table 75. Eisai Recent Development Table 76. Johnson & Johnson Company Information Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Johnson & Johnson General Anesthetics Product Portfolio Table 80. Johnson & Johnson Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Merck General Anesthetics Product Portfolio Table 85. Merck Recent Development Table 86. Jiangsu Hengrui Pharmaceutical Co., Ltd. Company Information Table 87. Jiangsu Hengrui Pharmaceutical Co., Ltd. Business Overview Table 88. Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Product Portfolio Table 90. Jiangsu Hengrui Pharmaceutical Co., Ltd. Recent Development Table 91. GlaxoSmithKline Company Information Table 92. GlaxoSmithKline Business Overview Table 93. GlaxoSmithKline General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. GlaxoSmithKline General Anesthetics Product Portfolio Table 95. GlaxoSmithKline Recent Development Table 96. Fresenius Kabi AG Company Information Table 97. Fresenius Kabi AG Business Overview Table 98. Fresenius Kabi AG General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Fresenius Kabi AG General Anesthetics Product Portfolio Table 100. Fresenius Kabi AG Recent Development Table 101. Baxter International Company Information Table 102. Baxter International Business Overview Table 103. Baxter International General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Baxter International General Anesthetics Product Portfolio Table 105. Baxter International Recent Development Table 106. AbbVie Company Information Table 107. AbbVie Business Overview Table 108. AbbVie General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. AbbVie General Anesthetics Product Portfolio Table 110. AbbVie Recent Development Table 111. AstraZeneca Company Information Table 112. AstraZeneca Business Overview Table 113. AstraZeneca General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. AstraZeneca General Anesthetics Product Portfolio Table 115. AstraZeneca Recent Development Table 116. Lannett Company Information Table 117. Lannett Business Overview Table 118. Lannett General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Lannett General Anesthetics Product Portfolio Table 120. Lannett Recent Development Table 121. Hikma Pharmaceuticals Company Information Table 122. Hikma Pharmaceuticals Business Overview Table 123. Hikma Pharmaceuticals General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Hikma Pharmaceuticals General Anesthetics Product Portfolio Table 125. Hikma Pharmaceuticals Recent Development Table 126. Endo International Company Information Table 127. Endo International Business Overview Table 128. Endo International General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Endo International General Anesthetics Product Portfolio Table 130. Endo International Recent Development Table 131. Boehringer Ingelheim Company Information Table 132. Boehringer Ingelheim Business Overview Table 133. Boehringer Ingelheim General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Boehringer Ingelheim General Anesthetics Product Portfolio Table 135. Boehringer Ingelheim Recent Development Table 136. B. Braun Melsungen AG Company Information Table 137. B. Braun Melsungen AG Business Overview Table 138. B. Braun Melsungen AG General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. B. Braun Melsungen AG General Anesthetics Product Portfolio Table 140. B. Braun Melsungen AG Recent Development Table 141. Aspen Pharmacare Company Information Table 142. Aspen Pharmacare Business Overview Table 143. Aspen Pharmacare General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Aspen Pharmacare General Anesthetics Product Portfolio Table 145. Aspen Pharmacare Recent Development Table 146. Abbott Laboratories Company Information Table 147. Abbott Laboratories Business Overview Table 148. Abbott Laboratories General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Abbott Laboratories General Anesthetics Product Portfolio Table 150. Abbott Laboratories Recent Development Table 151. North America General Anesthetics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. North America General Anesthetics Sales by Country (2021-2026) & (k units) Table 153. North America General Anesthetics Sales Market Share by Country (2021-2026) Table 154. North America General Anesthetics Sales Forecast by Country (2027-2032) & (k units) Table 155. North America General Anesthetics Sales Market Share Forecast by Country (2027-2032) Table 156. North America General Anesthetics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. North America General Anesthetics Market Size by Country (2021-2026) & (US$ Million) Table 158. North America General Anesthetics Market Share by Country (2021-2026) Table 159. North America General Anesthetics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. North America General Anesthetics Market Share Forecast by Country (2027-2032) Table 161. Europe General Anesthetics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Europe General Anesthetics Sales by Country (2021-2026) & (k units) Table 163. Europe General Anesthetics Sales Market Share by Country (2021-2026) Table 164. Europe General Anesthetics Sales Forecast by Country (2027-2032) & (k units) Table 165. Europe General Anesthetics Sales Market Share Forecast by Country (2027-2032) Table 166. Europe General Anesthetics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Europe General Anesthetics Market Size by Country (2021-2026) & (US$ Million) Table 168. Europe General Anesthetics Market Share by Country (2021-2026) Table 169. Europe General Anesthetics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Europe General Anesthetics Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific General Anesthetics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific General Anesthetics Sales by Country (2021-2026) & (k units) Table 173. Asia-Pacific General Anesthetics Sales Market Share by Country (2021-2026) Table 174. Asia-Pacific General Anesthetics Sales Forecast by Country (2027-2032) & (k units) Table 175. Asia-Pacific General Anesthetics Sales Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific General Anesthetics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific General Anesthetics Market Size by Country (2021-2026) & (US$ Million) Table 178. Asia-Pacific General Anesthetics Market Share by Country (2021-2026) Table 179. Asia-Pacific General Anesthetics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Asia-Pacific General Anesthetics Market Share Forecast by Country (2027-2032) Table 181. Latin America General Anesthetics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Latin America General Anesthetics Sales by Country (2021-2026) & (k units) Table 183. Latin America General Anesthetics Sales Market Share by Country (2021-2026) Table 184. Latin America General Anesthetics Sales Forecast by Country (2027-2032) & (k units) Table 185. Latin America General Anesthetics Sales Market Share Forecast by Country (2027-2032) Table 186. Latin America General Anesthetics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Latin America General Anesthetics Market Size by Country (2021-2026) & (US$ Million) Table 188. Latin America General Anesthetics Market Share by Country (2021-2026) Table 189. Latin America General Anesthetics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Latin America General Anesthetics Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa General Anesthetics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa General Anesthetics Sales by Country (2021-2026) & (k units) Table 193. Middle East and Africa General Anesthetics Sales Market Share by Country (2021-2026) Table 194. Middle East and Africa General Anesthetics Sales Forecast by Country (2027-2032) & (k units) Table 195. Middle East and Africa General Anesthetics Sales Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa General Anesthetics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa General Anesthetics Market Size by Country (2021-2026) & (US$ Million) Table 198. Middle East and Africa General Anesthetics Market Share by Country (2021-2026) Table 199. Middle East and Africa General Anesthetics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Middle East and Africa General Anesthetics Market Share Forecast by Country (2027-2032) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. General Anesthetics Distributors List Table 204. General Anesthetics Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. General Anesthetics Image Figure 2. Global General Anesthetics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global General Anesthetics Market Size (2021-2032) & (US$ Million) Figure 4. Global General Anesthetics Sales (2021-2032) & (k units) Figure 5. Inhalation Anesthestic Image Figure 6. Global Inhalation Anesthestic Sales YoY Growth (2021-2032) & (k units) Figure 7. Intravenous Anesthestic Image Figure 8. Global Intravenous Anesthestic Sales YoY Growth (2021-2032) & (k units) Figure 9. Global General Anesthetics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global General Anesthetics Market Share by Type 2025 VS 2032 Figure 11. North America General Anesthetics Sales Market Share in Volume by Type in 2025 Figure 12. North America General Anesthetics Sales Market Share in Value by Type in 2025 Figure 13. Europe General Anesthetics Sales Market Share in Volume by Type in 2025 Figure 14. Europe General Anesthetics Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific General Anesthetics Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific General Anesthetics Sales Market Share in Value by Type in 2025 Figure 17. Latin America General Anesthetics Sales Market Share in Volume by Type in 2025 Figure 18. Latin America General Anesthetics Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa General Anesthetics Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa General Anesthetics Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 General Anesthetics Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Ambulatory Surgery Center Image Figure 26. Global Ambulatory Surgery Center Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global General Anesthetics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global General Anesthetics Market Share by Application 2025 VS 2032 Figure 31. North America General Anesthetics Sales Market Share in Volume by Application in 2025 Figure 32. North America General Anesthetics Sales Market Share in Value by Application in 2025 Figure 33. Europe General Anesthetics Sales Market Share in Volume by Application in 2025 Figure 34. Europe General Anesthetics Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific General Anesthetics Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific General Anesthetics Sales Market Share in Value by Application in 2025 Figure 37. Latin America General Anesthetics Sales Market Share in Volume by Application in 2025 Figure 38. Latin America General Anesthetics Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa General Anesthetics Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa General Anesthetics Sales Market Share in Value by Application in 2025 Figure 41. North America General Anesthetics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America General Anesthetics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America General Anesthetics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America General Anesthetics Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe General Anesthetics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe General Anesthetics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe General Anesthetics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe General Anesthetics Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific General Anesthetics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific General Anesthetics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific General Anesthetics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific General Anesthetics Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America General Anesthetics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America General Anesthetics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America General Anesthetics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America General Anesthetics Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa General Anesthetics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa General Anesthetics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa General Anesthetics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa General Anesthetics Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. General Anesthetics Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. General Anesthetics Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Inhalation Anesthestic
  • Intravenous Anesthestic
Applications
  • Hospital
  • Ambulatory Surgery Center
  • Others
Companies covered
  • Eisai
  • Johnson & Johnson
  • Merck
  • Jiangsu Hengrui Pharmaceutical Co., Ltd.
  • GlaxoSmithKline
  • Fresenius Kabi AG
  • Baxter International
  • AbbVie
  • AstraZeneca
  • Lannett
  • Hikma Pharmaceuticals
  • Endo International
  • Boehringer Ingelheim
  • B. Braun Melsungen AG
  • Aspen Pharmacare
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global General Anesthetics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global General Anesthetics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 General Anesthetics Market by Type
  6. 1.3.1 Inhalation Anesthestic
  7. 1.3.2 Intravenous Anesthestic
  8. 1.4 Global General Anesthetics Market Size by Type
  9. 1.4.1 Global General Anesthetics Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global General Anesthetics Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global General Anesthetics Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America General Anesthetics Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe General Anesthetics Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific General Anesthetics Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America General Anesthetics Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa General Anesthetics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 General Anesthetics Industry Trends
  2. 2.2 General Anesthetics Industry Drivers
  3. 2.3 General Anesthetics Industry Opportunities and Challenges
  4. 2.4 General Anesthetics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by General Anesthetics Revenue (2021-2026)
  2. 3.2 Global Top Players by General Anesthetics Sales (2021-2026)
  3. 3.3 Global Top Players by General Anesthetics Price (2021-2026)
  4. 3.4 Global General Anesthetics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global General Anesthetics Major Company Production Sites & Headquarters
  6. 3.6 Global General Anesthetics Company, Product Type & Application
  7. 3.7 Global General Anesthetics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global General Anesthetics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 General Anesthetics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 General Anesthetics Tier 1, Tier 2, and Tier 3
4 General Anesthetics Regional Status and Outlook
  1. 4.1 Global General Anesthetics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global General Anesthetics Historic Market Size by Region
  3. 4.2.1 Global General Anesthetics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global General Anesthetics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global General Anesthetics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global General Anesthetics Forecasted Market Size by Region
  7. 4.3.1 Global General Anesthetics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global General Anesthetics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global General Anesthetics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 General Anesthetics by Application
  1. 5.1 General Anesthetics Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Ambulatory Surgery Center
  4. 5.1.3 Others
  5. 5.2 Global General Anesthetics Market Size by Application
  6. 5.2.1 Global General Anesthetics Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global General Anesthetics Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global General Anesthetics Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America General Anesthetics Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe General Anesthetics Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific General Anesthetics Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America General Anesthetics Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa General Anesthetics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eisai
  2. 6.1.1 Eisai Company Information
  3. 6.1.2 Eisai Business Overview
  4. 6.1.3 Eisai General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eisai General Anesthetics Product Portfolio
  6. 6.1.5 Eisai Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson General Anesthetics Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck General Anesthetics Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Jiangsu Hengrui Pharmaceutical Co., Ltd.
  20. 6.4.1 Jiangsu Hengrui Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Jiangsu Hengrui Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Product Portfolio
  24. 6.4.5 Jiangsu Hengrui Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline General Anesthetics Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Fresenius Kabi AG
  32. 6.6.1 Fresenius Kabi AG Company Information
  33. 6.6.2 Fresenius Kabi AG Business Overview
  34. 6.6.3 Fresenius Kabi AG General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Fresenius Kabi AG General Anesthetics Product Portfolio
  36. 6.6.5 Fresenius Kabi AG Recent Developments
  37. 6.7 Baxter International
  38. 6.7.1 Baxter International Company Information
  39. 6.7.2 Baxter International Business Overview
  40. 6.7.3 Baxter International General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Baxter International General Anesthetics Product Portfolio
  42. 6.7.5 Baxter International Recent Developments
  43. 6.8 AbbVie
  44. 6.8.1 AbbVie Company Information
  45. 6.8.2 AbbVie Business Overview
  46. 6.8.3 AbbVie General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AbbVie General Anesthetics Product Portfolio
  48. 6.8.5 AbbVie Recent Developments
  49. 6.9 AstraZeneca
  50. 6.9.1 AstraZeneca Company Information
  51. 6.9.2 AstraZeneca Business Overview
  52. 6.9.3 AstraZeneca General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca General Anesthetics Product Portfolio
  54. 6.9.5 AstraZeneca Recent Developments
  55. 6.10 Lannett
  56. 6.10.1 Lannett Company Information
  57. 6.10.2 Lannett Business Overview
  58. 6.10.3 Lannett General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Lannett General Anesthetics Product Portfolio
  60. 6.10.5 Lannett Recent Developments
  61. 6.11 Hikma Pharmaceuticals
  62. 6.11.1 Hikma Pharmaceuticals Company Information
  63. 6.11.2 Hikma Pharmaceuticals Business Overview
  64. 6.11.3 Hikma Pharmaceuticals General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hikma Pharmaceuticals General Anesthetics Product Portfolio
  66. 6.11.5 Hikma Pharmaceuticals Recent Developments
  67. 6.12 Endo International
  68. 6.12.1 Endo International Company Information
  69. 6.12.2 Endo International Business Overview
  70. 6.12.3 Endo International General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Endo International General Anesthetics Product Portfolio
  72. 6.12.5 Endo International Recent Developments
  73. 6.13 Boehringer Ingelheim
  74. 6.13.1 Boehringer Ingelheim Company Information
  75. 6.13.2 Boehringer Ingelheim Business Overview
  76. 6.13.3 Boehringer Ingelheim General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Boehringer Ingelheim General Anesthetics Product Portfolio
  78. 6.13.5 Boehringer Ingelheim Recent Developments
  79. 6.14 B. Braun Melsungen AG
  80. 6.14.1 B. Braun Melsungen AG Company Information
  81. 6.14.2 B. Braun Melsungen AG Business Overview
  82. 6.14.3 B. Braun Melsungen AG General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 B. Braun Melsungen AG General Anesthetics Product Portfolio
  84. 6.14.5 B. Braun Melsungen AG Recent Developments
  85. 6.15 Aspen Pharmacare
  86. 6.15.1 Aspen Pharmacare Company Information
  87. 6.15.2 Aspen Pharmacare Business Overview
  88. 6.15.3 Aspen Pharmacare General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Aspen Pharmacare General Anesthetics Product Portfolio
  90. 6.15.5 Aspen Pharmacare Recent Developments
  91. 6.16 Abbott Laboratories
  92. 6.16.1 Abbott Laboratories Company Information
  93. 6.16.2 Abbott Laboratories Business Overview
  94. 6.16.3 Abbott Laboratories General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Abbott Laboratories General Anesthetics Product Portfolio
  96. 6.16.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America General Anesthetics Sales by Country
  2. 7.1.1 North America General Anesthetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America General Anesthetics Sales by Country (2021-2026)
  4. 7.1.3 North America General Anesthetics Sales Forecast by Country (2027-2032)
  5. 7.2 North America General Anesthetics Market Size by Country
  6. 7.2.1 North America General Anesthetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America General Anesthetics Market Size by Country (2021-2026)
  8. 7.2.3 North America General Anesthetics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe General Anesthetics Sales by Country
  2. 8.1.1 Europe General Anesthetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe General Anesthetics Sales by Country (2021-2026)
  4. 8.1.3 Europe General Anesthetics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe General Anesthetics Market Size by Country
  6. 8.2.1 Europe General Anesthetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe General Anesthetics Market Size by Country (2021-2026)
  8. 8.2.3 Europe General Anesthetics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific General Anesthetics Sales by Country
  2. 9.1.1 Asia-Pacific General Anesthetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific General Anesthetics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific General Anesthetics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific General Anesthetics Market Size by Country
  6. 9.2.1 Asia-Pacific General Anesthetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific General Anesthetics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific General Anesthetics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America General Anesthetics Sales by Country
  2. 10.1.1 South America General Anesthetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America General Anesthetics Sales by Country (2021-2026)
  4. 10.1.3 South America General Anesthetics Sales Forecast by Country (2027-2032)
  5. 10.2 South America General Anesthetics Market Size by Country
  6. 10.2.1 South America General Anesthetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America General Anesthetics Market Size by Country (2021-2026)
  8. 10.2.3 South America General Anesthetics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa General Anesthetics Sales by Country
  2. 11.1.1 Middle East and Africa General Anesthetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa General Anesthetics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa General Anesthetics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa General Anesthetics Market Size by Country
  6. 11.2.1 Middle East and Africa General Anesthetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa General Anesthetics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa General Anesthetics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 General Anesthetics Value Chain Analysis
  2. 12.1.1 General Anesthetics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 General Anesthetics Production Mode & Process
  7. 12.2 General Anesthetics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 General Anesthetics Distributors
  10. 12.2.3 General Anesthetics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research